Health / Cardiovascular Disease

Cytokinetics' Myqorzo Meets Goals in Genetic Heart Disease Study

Cytokinetics' drug, Myqorzo, has demonstrated significant improvements in heart failure symptoms and cardiovascular fitness for patients with non-obstructive hypertrophic cardiomyopathy (HCM), an inherited heart disorder. This development c...